David P. Southwell - 08 Sep 2021 Form 4 Insider Report for TScan Therapeutics, Inc. (TCRX)

Role: Chief Executive Officer, Director
Signature: /s/ David P. Southwell
Issuer symbol: TCRX
Transactions as of: 08 Sep 2021
Net transactions value: +$96,066
Form type: 4
Filing time: 09 Sep 2021, 16:43:38 UTC
Previous filing: 15 Jul 2021
Next filing: 27 Dec 2021
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	TCRX	Voting Common Stock	Purchase	$96,066	+11,000	+13%	$8.73	97,899	08 Sep 2021	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The price reported in Column 4 is a weighted average price. These securities were purchased in multiple transactions at prices ranging from $8.64 to $8.75, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of securities purchased at each separate price within the ranges set forth in this footnote (1) to this Form 4.

Content

The price reported in Column 4 is a weighted average price. These securities were purchased in multiple transactions at prices ranging from $8.64 to $8.75, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of securities purchased at each separate price within the ranges set forth in this footnote (1) to this Form 4.